文献速递淋巴瘤造血干细胞移植与细胞治疗

S-2HG增加中枢记忆CD8细胞并改善CAR-T疗效

The S enantiomer of 2-hydroxyglutarate increases central memory CD8 populations and improves CAR-T therapy outcome.
PubMed 文献 · Blood Adv · 2020-01-01

该研究基于前期小鼠发现,在临床级人供者CAR-T细胞制备中,用免疫代谢物2-羟基戊二酸的S对映体(S-2HG)培养初始CD8前体,所得CAR-T细胞可在体内建立长期记忆,抗肿瘤反应优于标准方案,为B细胞恶性肿瘤的1期临床试验提供依据。

要点

  • S-2HG处理可自初始前体生成临床级人CAR-T细胞。
  • S-2HG处理的CAR-T细胞体内建立长期记忆并增强抗肿瘤反应。
  • 结果为S-2HG处理CD19-CAR-T的1期临床试验提供依据。

核心结论

  • S-2HG处理的临床级人供者CAR-T细胞可在体内建立长期记忆并显示优于标准方案的抗肿瘤反应。

研究设计与样本

  • 基于人供者临床级CAR-T细胞的体外培养与体内功能评价研究。

主要发现

  • S-2HG处理的CAR-T细胞可在体内建立长期记忆细胞。
  • 与标准临床方案生成的CAR-T细胞相比,S-2HG处理组抗肿瘤反应更优。
  • 临床级人供者CAR-T细胞可自初始前体经S-2HG培养生成。

临床怎么用

  • 为评估S-2HG处理CD19-CAR-T细胞在B细胞恶性肿瘤患者中活性的1期临床试验提供依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cancer immunotherapy is advancing rapidly and gene-modified T cells expressing chimeric antigen receptors (CARs) show particular promise. A challenge of CAR-T cell therapy is that the ex vivo-generated CAR-T cells become exhausted during expansion in culture, and do not persist when transferred back to patients. It has become clear that naive and memory CD8 T cells perform better than the total CD8 T-cell populations in CAR-T immunotherapy because of better expansion, antitumor activity, and persistence, which are necessary features for therapeutic success and prevention of disease relapse. However, memory CAR-T cells are rarely used in the clinic due to generation challenges. We previously reported that mouse CD8 T cells cultured with the S enantiomer of the immunometabolite 2-hydroxyglutarate (S-2HG) exhibit enhanced antitumor activity. Here, we show that clinical-grade human donor CAR-T cells can be generated from naive precursors after culture with S-2HG. S-2HG-treated CAR-T cells establish long-term memory cells in vivo and show superior antitumor responses when compared with CAR-T cells generated with standard clinical protocols. This study provides the basis for a phase 1 clinical trial evaluating the activity of S-2HG-treated CD19-CAR-T cells in patients with B-cell malignancies.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Foskolou IP, Barbieri L, Vernet A, et al. The S enantiomer of 2-hydroxyglutarate increases central memory CD8 populations and improves CAR-T therapy outcome. Blood Adv. 2020. PMID: 32941648. doi:10.1182/bloodadvances.2020002309

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。